Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2012
04/17/2012CA2347928C Cell surface molecule-induced macrophage activation
04/17/2012CA2225378C Cytokine that induces apoptosis
04/13/2012CA2752372A1 Method for treating diabetes
04/12/2012WO2012048291A2 Compositions and methods for inhibition of mmp:mmp-substrate interactions
04/12/2012WO2012048161A2 Molecular death tags and methods of their use
04/12/2012WO2012048063A2 Cyanine compounds, conjugates and method of use
04/12/2012WO2012047954A1 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
04/12/2012WO2012047732A2 Antibody compositions and methods of use
04/12/2012WO2012047584A2 Macaca fascicularis ccl17
04/12/2012WO2012047583A2 Antibodies binding human collagen ii
04/12/2012WO2012047567A1 Anti-cd48 antibodies and uses thereof
04/12/2012WO2012047317A2 Tumor specific antibodies and uses therefor
04/12/2012WO2012046745A1 Therapeutic agent for malignant tumors expressing mhc class ii
04/12/2012WO2012046730A1 Method for activating helper t cell
04/12/2012WO2012046563A1 Monoclonal antibody which recognizes ciguatoxins ctx1b and 54-deoxy-ctx1b, and ciguatoxin detection kit using same
04/12/2012WO2012046081A1 Malaria vaccine
04/12/2012WO2012046001A1 Method to inhibit recruitment of monocytes and macrophages by an icam-3 inhibitor
04/12/2012WO2012045882A2 Pharmaceutical composition
04/12/2012WO2012045848A1 Methods of treating psoriasis using il-17 antagonists
04/12/2012WO2012045776A1 Antagonist antibody of endothelin receptor subtype b, and uses thereof
04/12/2012WO2012045752A1 Cd33 binding agents
04/12/2012WO2012045703A1 Anti-il12rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders
04/12/2012WO2012045671A1 Antibodies against human tweak and uses thereof
04/12/2012WO2012045587A1 A new method for diagnosing hypertension as well as cardiomyopathies
04/12/2012WO2012045481A2 Antibody targeting osteoclast-related protein siglec-15
04/12/2012WO2012045331A1 Hybrid process for the purification of biomolecules
04/12/2012WO2012020006A3 Anti-fap antibodies and methods of use
04/12/2012WO2012018801A9 Suppressing bone loss with anti-il-19 antibody
04/12/2012WO2012017327A3 Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv
04/12/2012WO2012017323A3 Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv
04/12/2012WO2012011144A3 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
04/12/2012WO2012009442A3 Anti-addl monoclonal antibody and uses thereof
04/12/2012WO2012007950A3 Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
04/12/2012WO2012007880A3 Modified single domain antigen binding molecules and uses thereof
04/12/2012WO2012007847A3 Pharmaceutical compositions and methods of treatment
04/12/2012WO2012007846A3 A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
04/12/2012WO2012006500A3 Monoclonal antibodies against hepatitis c virus core protein
04/12/2012WO2012003493A3 Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of use
04/12/2012WO2011130650A3 Antibodies for the treatment of clostridium difficile-associated infection and disease
04/12/2012WO2011103330A3 Novel phosphorylation of cardiac troponin i as a monitor for cardiac injury
04/12/2012WO2011100477A3 Antibodies and processes for preparing the same
04/12/2012WO2011067711A3 Novel heparanase splice variant
04/12/2012WO2011050188A8 Anti-hepsin antibodies and methods using same
04/12/2012US20120090044 Indoleamine 2,3-Dioxygenase-2
04/12/2012US20120090043 Targets for retrovirus associated diseases
04/12/2012US20120089541 Biomarkers and methods of treatment
04/12/2012US20120089076 Method for treating inflammation
04/12/2012US20120088905 Fc VARIANTS WITH ALTERED BINDING TO FcRn
04/12/2012US20120088732 Therapeutic composition comprising a botulinum neurotoxin
04/12/2012US20120088722 Compositions and methods for inhibition of mmp:mmp-substrate interactions
04/12/2012US20120088718 Hcv-derived polypeptides and uses thereof
04/12/2012US20120088681 Methods and kits used in classifying adrenocortical carcinoma
04/12/2012US20120088312 Vincristine immunoassay
04/12/2012US20120088297 Mycobacterial antigens expressed under low oxygen tension
04/12/2012US20120088287 Cripto antagonism of activin and tgf-b signaling
04/12/2012US20120088262 Cyanine compounds, conjugates and method of use
04/12/2012US20120087939 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
04/12/2012US20120087932 Diagnostic test for virus
04/12/2012US20120087931 Therapeutic and diagnostic anti-hsp70 antibodies
04/12/2012US20120087927 Antibody containing igg2 having amino acid mutation introduced therein
04/12/2012US20120087926 Chicken-derived anti-lox-1 antibody
04/12/2012US20120087925 Method for the treatment of inflammatory disorders
04/12/2012US20120087924 Recombinant B. pseudomallei Adhesin Protein and Methods and Uses Thereof
04/12/2012US20120087923 Antibodies to OPGL
04/12/2012US20120087919 Method for treating diabetes
04/12/2012US20120087918 Methods and compositions for inhibiting the growth of hematopoietic malignant cells
04/12/2012US20120087917 Lox and loxl2 inhibitors and uses thereof
04/12/2012US20120087916 Anti-icam-1 antibody, uses and methods
04/12/2012US20120087912 Treatment methods using dkk-1 antibodies
04/12/2012US20120087911 Crystal structure
04/12/2012US20120087909 Neutralizing monoclonal antibodies to respiratory syncytial virus
04/12/2012US20120087870 Novel caviidae allergens and uses thereof
04/12/2012US20120087862 Organ-specific proteins and methods of their use
04/12/2012US20120087861 Human Anti-Tau Antibodies
04/12/2012US20120087858 Dual variable domain immunoglobulins and uses thereof
04/12/2012CA2819010A1 Method to inhibit recruitment of monocytes and macrophages by an icam-3 inhibitor
04/12/2012CA2814040A1 A monoclonal antibody framework binding interface for meditopes, meditope delivery systems and methods for their use
04/12/2012CA2813900A1 Methods of treating psoriasis using il-17 antagonists
04/12/2012CA2813814A1 Tumor specific antibodies and uses therefor
04/12/2012CA2813738A1 Mutant smoothened and methods of using the same
04/12/2012CA2813587A1 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
04/12/2012CA2813557A1 Method for activating helper t cell
04/12/2012CA2813497A1 A new method for diagnosing hypertension as well as cardiomyopathies
04/12/2012CA2813314A1 Antibody targeting osteoclast-related protein siglec-15
04/12/2012CA2812865A1 Phosphospecific antibodies recognising tau
04/12/2012CA2812748A1 Anti-cd48 antibodies and uses thereof
04/12/2012CA2812731A1 Clostridium difficile antigens
04/12/2012CA2812392A1 Macaca fascicularis ccl17
04/12/2012CA2812389A1 Antibodies binding human collagen ii
04/12/2012CA2811087A1 Antibody compositions and methods of use
04/12/2012CA2809925A1 Cd33 binding agents
04/12/2012CA2809632A1 Antibodies against human tweak and uses thereof
04/11/2012EP2439273A2 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
04/11/2012EP2439272A2 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
04/11/2012EP2439269A1 Expression vector for establishing hyper-producing cells, and hyper-producing cells
04/11/2012EP2439213A1 Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
04/11/2012EP2439212A1 Improved fibronectin-based binding molecules and uses thereof
04/11/2012EP2438171A1 Fucosylation-deficient cells
04/11/2012EP2438090A1 Amino acid sequences which enhance peptide conjugate solubility
04/11/2012EP2438089A1 TREATMENT OF ONCOSTATIN M RECEPTOR ß MEDIATED HEART FAILURE
1 ... 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 ... 1494